Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
CLNN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -50.4%
CLNN
Clene Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
clene
nasdaq
sclerosis
clinical
price
analyst
announced
trading
after
ratings
analysts
2024
today
target
2023
stage
biopharmaceutical
neurodegenerative
focused
revenue
StonvexStonvexStonvexStonvex